Recent News

• 08.06.2025 - MaxCyte Second Quarter Earnings Conference Call
• 08.06.2025 - MaxCyte Second Quarter Earnings Conference Call
• 08.06.2025 - MaxCyte Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Guidance
• 08.06.2025 - MaxCyte Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Guidance
• 08.04.2025 - MaxCyte Signs Platform License Agreement with Adicet Bio
• 08.04.2025 - MaxCyte Signs Platform License Agreement with Adicet Bio
• 07.31.2025 - MaxCyte Announces Strategic Platform Licensing Agreement with Anocca AB to Advance TCR-T Cell Therapy Pipeline
• 07.31.2025 - MaxCyte Announces Strategic Platform Licensing Agreement with Anocca AB to Advance TCR-T Cell Therapy Pipeline
• 07.23.2025 - Hannah Hefley
• 07.09.2025 - MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025

Recent Filings

• 08.06.2025 - 8-K Current report
• 08.06.2025 - EX-99.1 EX-99.1
• 08.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 06.25.2025 - 144 Report of proposed sale of securities
• 06.25.2025 - 8-K Current report
• 06.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.23.2025 - 4 Statement of changes in beneficial ownership of securities